BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30012345)

  • 1. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V; Singhal L; Ray P
    Indian J Med Microbiol; 2011; 29(1):4-12. PubMed ID: 21304187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species distribution and antimicrobial susceptibility of Burkholderia cepacia complex isolates in clinical infections: Experience from a tertiary care hospital, Southern India.
    Kumaresan M; Manoharan M; Sugumar M; Sistla S
    Indian J Med Microbiol; 2024; 49():100613. PubMed ID: 38750965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods.
    Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.
    Abbott FK; Milne KE; Stead DA; Gould IM
    Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteria of the Burkholderia cepacia complex: epidemiology and diagnosis of infection in patients with cystic fibrosis].
    Dřevínek P
    Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):18-26. PubMed ID: 24730990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T; Ozkaya Parlakay A; Aygar IS; Gulhan B; Kanik Yuksek S
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
    Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M
    J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.
    da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370
    [TBL] [